Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Capecitabine
Sponsor: Latin American & Caribbean Society of Medical Oncology
Collaborators: Breast Cancer Research Foundation